Table 3.
Influence of diabetes, hypertension, dyslipemia, and metabolic syndrome on the prevalence of MCI in patients with NAFLD.
| Patients | Patients with MCI | Total Patients | Prevalence of MCI (%) |
|---|---|---|---|
| Total | 19 | 59 | 32 |
| With diabetes | 11 | 29 | 38 |
| Without diabetes | 8 | 30 | 27 |
| With hypertension | 11 | 33 | 33 |
| Without hypertension | 8 | 26 | 31 |
| With dyslipemia | 11 | 37 | 30 |
| Without dyslipemia | 8 | 22 | 36 |
| With metabolic syndrome | 11 | 30 | 37 |
| Without metabolic syndrome | 8 | 29 | 28 |
MCI: Mild cognitive impairment; NAFLD: Nonalcoholic fatty liver disease.